Analysts at StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the technology company’s stock.
Separately, HC Wainwright reduced their price target on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating for the company in a research report on Monday, June 10th.
Read Our Latest Analysis on Applied DNA Sciences
Applied DNA Sciences Price Performance
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last issued its earnings results on Friday, May 10th. The technology company reported ($5.31) EPS for the quarter, missing the consensus estimate of ($4.60) by ($0.71). The company had revenue of $0.93 million for the quarter, compared to analysts’ expectations of $0.90 million. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. Equities research analysts expect that Applied DNA Sciences will post -2.95 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Applied DNA Sciences
A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC purchased a new stake in Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences at the end of the most recent reporting period. Institutional investors and hedge funds own 22.22% of the company’s stock.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Recommended Stories
- Five stocks we like better than Applied DNA Sciences
- The Most Important Warren Buffett Stock for Investors: His Own
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- Most active stocks: Dollar volume vs share volume
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.